[Antibiotic treatment of device-associated endocarditis with fosfomycin and vancomycin in patients with renal insufficiency].
Bär
W
W
Institut für Medizinische Mikrobiologie, Carl-Thiem Klinikum, Cottbus. baer@ctk.de
Grosch
H
H
Ahland
R
R
Krülls-Münch
J
J
D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D017147:Defibrillators, Implantable / Q000382:microbiology; D004359:Drug Therapy, Combination; D004697:Endocarditis, Bacterial / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D005578:Fosfomycin / Q000627:therapeutic use*; D006350:Heart Valve Prosthesis / Q000382:microbiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D010138:Pacemaker, Artificial / Q000382:microbiology; D016459:Prosthesis-Related Infections / Q000188:drug therapy* / Q000209:etiology; D051437:Renal Insufficiency / Q000150:complications*; D014640:Vancomycin / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D005578:Fosfomycin; D014640:Vancomycin